Skip to content
Press Release
FEATURED | May 1, 2026

Jason Chambers Teams Up with the Melanoma Researc...

Superyacht Captain, Star of Bravo’s “Below Deck Down Under” and Melanoma Advocate Urges All to Embrace Healthy Sun-Safe Behaviors and #GetNaked…It May Save Your...

5 Minute Read
February 27, 2026

Using tumor macrophage function to predict immunot...

Bryan Weselman’s Abstract While new treatment options for metastatic melanoma that activate the immune system to target cancer have helped some patients live longer,...

1 Minute Read
February 27, 2026

Shade Availability and Social Determinants of Mela...

Joy Xie’s Abstract Skin cancer is the most common cancer in the United States, and nearly one in five Americans will develop it during their lifetime. While most pr...

2 Minute Read
September 29, 2025

Leveraging GSDMD-Mediated Pyroptosis as a Therap...

Dan Erkes‘s Abstract Melanoma is the most lethal skin cancer, leading to an estimated 8,290 deaths and 100,640 new cases in 2024. Melanoma was traditionally ...

3 Minute Read
September 29, 2025

VISTA-Positive Neutrophils in Melanoma Immunothera...

Daniel Hirschhorn‘s Abstract Immunotherapy has greatly improved survival for people with melanoma, but many patients also experience harmful side effects wh...

1 Minute Read
September 29, 2025

Mapping the Death and Growth of Tumor Cells in Mel...

Kenneth Hu‘s Abstract Immunotherapies including immune checkpoint blockade (ICB) have seen remarkable success in the clinic. Unfortunately, many patients with late-st...

3 Minute Read
September 29, 2025

Investigating the Role of Cancer-Associated Fibrob...

Emily Bernstein‘s Abstract Melanoma is the most lethal skin cancer, and the success of current therapies remains limited. To better tailor melanoma treatments, we m...

2 Minute Read
September 29, 2025

Pedigree Approach to Identify Predisposition Varia...

Lisa Cannon-Albright‘s Abstract Analysis of large families with more disease than expected has been shown to be a powerful way to identify cancer predisposition g...

2 Minute Read
September 29, 2025

Next-Generation RAF-Targeting Strategies for RAS-M...

Mathieu Desaunay‘s Abstract Skin cancer is one of the most common types of cancer, with melanoma being the deadliest form. In the United States, approximately 104,9...

3 Minute Read
September 29, 2025

Redirecting Antiviral Immune Responses to Elimina...

Thorsten Mempel‘s Abstract While immunotherapy has greatly improved the survival for patients with melanoma of the sun-exposed skin, especially for those with adva...

3 Minute Read
September 29, 2025

Overcoming Drug Resistance in NRAS-Mutant Melanoma...

Hee Won Yang‘s Abstract Melanoma is an aggressive type of skin cancer known for its rapid spread and frequent resistance to current treatments. Many advanced melanoma...

1 Minute Read
September 29, 2025

 Inhibiting ligand-driven BMP Signaling to Overco...

Craig Ceol‘s Abstract The use of immunotherapies has revolutionized treatment for late-stage melanoma patients. These therapies have extended survival for many patien...

3 Minute Read
July 11, 2025

A/B Testing of Patient Decision Aids for Dysplasti...

Jaclyn Roland-McGowan’s Abstract This research project explores how different versions of a patient decision aid can help people make informed choices about their ski...

1 Minute Read

May 26, 2026 ET

Ask the Expert: Understanding Melanoma Risk: How Prognostic Testing Can Help Guide Your Care

Jun 13, 2026 MT

Denver Miles for Melanoma 5K

Jul 19, 2026 CT

Chicago Miles for Melanoma 5K

Aug 02, 2026 ET

Cleveland Miles for Melanoma 5K

Aug 22, 2026 ET

Philadelphia Miles for Melanoma 5K

Aug 30, 2026 PT

San Francisco Miles for Melanoma 5K

Aug 30, 2026 CT

Twin Cities Miles for Melanoma 5K

Explore Events